News and Announcements
EDFA presents: The $110m Health Common Richlands Project | EDFA offering Exclusive $10m Allocation for Investors
- Published June 01, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Inspired by community integrated health centres in the UK. The Health Commons Richlands aims to transform the local community by providing a comprehensive neighbourhood hub with medical, health, Specialist Disability Accommodation, respite care accommodation and wellbeing facilities.
The hub will be spread over 13,300m2 and have a value of over $110M upon completion. With specialist tenants and a community feel, this health hub will be a jewel in the suburb of Richlands, Brisbane. The precinct will house many specialists ranging for GP’s, pharmacy, radiology, physiotherapy, psychology, optometry, allied health with a hydrotherapy pool and 40 apartments designed for NDIS participants plus people in need of respite care.
The Health Common has attracted a lot of attention from tenants, funders, politicians and buyers of a completed asset. They are partnering with a listed REIT to fund the construction and acquire the asset, securing an exit for investors.
The opportunity for investors is to participate in the early-stage capital for a financial and social ROI.
EDFA can place up to $10M into the project. Time is short and the opportunity is exclusive.
Enquire today.
About Ethical Development Fund Australia
Ethical Development Fund Australia is an investment manager in the ethical and impact sector. Our mission is to invest and fund projects that have a significant financial and social return on investment. We seek to generate positive outcomes for people, communities, environments and investors.
Capital raised will be invested into medical and allied health projects, disability housing, key worker housing, renewable energy. Projects that can demonstrate an ethical overlay or social impact allow us to broaden the scope of the fund into areas such as fintech, data storage, water, hydrogen, agriculture.
We have an incredible pipeline of projects that will pay social dividends and allow the Ethical Development Fund Australia to be a leader in certain fields, maintaining a capital with purpose mantra.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
